Related Experiment Video
Updated: Apr 4, 2026

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
[Lysosomal storage diseases: A brief summary]
1Abteilung für Neuropathologie des Pathologischen Instituts, Universität Tübingen, Tübingen, Deutschland.
Insights
Pathologists can identify lysosomal storage diseases (LSDs) by examining cellular morphology, particularly in bone marrow. While initial identification is possible, confirmation requires genetic and biochemical tests, emphasizing collaborative diagnostics.
Area of Science:
- Histopathology
- Cellular Biology
- Medical Diagnostics
Context:
- Lysosomal storage diseases (LSDs) are a diverse group of genetic disorders that can affect individuals of all ages.
- Histiocytic diseases often require a broad differential diagnosis that includes LSDs.
- Recognizing morphological storage phenomena is crucial for diagnosing various LSDs.
Purpose:
- To evaluate the diagnostic contribution of pathologists in identifying lysosomal storage diseases (LSDs).
- To highlight the role of morphological analysis in the preliminary diagnosis of LSDs.
- To underscore the importance of interdisciplinary collaboration in diagnosing complex LSDs.
Summary:
- Pathologists can identify specific lysosomal storage diseases (LSDs) through detailed ultrastructural analysis of histiocytic storage cells in bone marrow smears and tissue samples.
- Morphological differentiation allows for the preliminary identification of LSDs like Gaucher disease, Niemann-Pick disease, cholesteryl ester storage disease (CESD), and GM1 gangliosidosis.
- While pathologists can suspect LSDs, definitive diagnosis necessitates confirmatory genetic and biochemical analyses.
Impact:
- Enhances the early detection of lysosomal storage diseases (LSDs) by leveraging pathological findings.
- Improves diagnostic accuracy for rare and heterogeneous LSDs through specialized morphological examination.
- Promotes a multidisciplinary approach involving clinicians, pathologists, geneticists, and biochemists for comprehensive LSD diagnosis and management.
Background:
A considerable number of lysosomal storage diseases (LSD), which can occur at any age in life, should be included in the differential diagnosis of histiocytic diseases.
Objective:
To what extent can pathologists contribute to the diagnostics of LSD?
Material And Methods:
In material collected from LSD, morphological storage phenomena in some disease forms, particularly in histiocytic cells from bone marrow smears and some tissues are highlighted, presented and described. Due to the multitude and heterogeneity of LSDs this list is by no means exhaustive.
Results:
In Gaucher disease, the forms of Niemann-Pick disease, cholesteryl ester storage disease (CESD), GM1 gangliosidosis and other LSDs, the histiocytic storage cells seen, for example, in bone marrow smears can be finely and ultrastructurally differentiated. Thereby, not only the presence of an LSD in general but also some individual types of LSD can be identified, even though preliminarily. To confirm the diagnosis the genetic and sometimes biochemical analysis of blood samples or fibroblast cultures from patients is usually required.
Conclusion:
The pathologist may be the first to suspect LSD and this applies to LSDs that show storage histiocytes or one of a number of other LSDs in which only minor or absent storage is seen in histiocytes but marked storage phenomena are found in other cell systems. Some of the numerous, extremely heterogeneous LSDs may, however, be overlooked as detailed knowledge of the generally rare LSDs is the domain of LSD specialists. Clinicians, pathologists, geneticists and biochemists should cooperate in solving the diagnostic problems.
More Related Videos
Related Concept Videos
Lysosomal Hydrolases
Inborn Errors of Metabolism
Lysosomes
Lysosomes
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Protein Import into the Peroxisomes
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...

